Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice | Zendy

Fabrizio Montecucco | Zendy; Sébastien Lenglet | Zendy; Vincent Braunersreuther | Zendy; Graziano Pelli | Zendy; Corinne Pellieux | Zendy; Christophe Montessuit | Zendy; René Lerch | Zendy; Maud Déruaz | Zendy; Amanda Proudfoot | Zendy; François Mach | Zendy

Open Access

Single Administration of the CXC Chemokine-Binding Protein Evasin-3 During Ischemia Prevents Myocardial Reperfusion Injury in Mice

Author(s) -

Fabrizio Montecucco,

Sébastien Lenglet,

Vincent Braunersreuther,

Graziano Pelli,

Corinne Pellieux,

Christophe Montessuit,

René Lerch,

Maud Déruaz,

Amanda Proudfoot,

François Mach

Publication year - 2010

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.110.206011

Subject(s) - chemokine , ischemia , reperfusion injury , medicine , myocardial infarction , coronary occlusion , pharmacology , cardiology , ligature , in vivo , immunology , inflammation , biology , microbiology and biotechnology

Evasins (chemokine-binding proteins) have been shown to selectively neutralize chemokine bioactivity. We investigated the potential benefits of Evasin-3 on mouse myocardial ischemia/reperfusion injury.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog